Laurent Arthaud
Director/Board Member bij CELLECTIS S.A.
Oorsprong van het eerstegraads netwerk van Laurent Arthaud
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
BPIFrance Investissement SAS
BPIFrance Investissement SAS Investment ManagersFinance BPIFrance Investissement SAS (BPIfrance Investissement) is the private equity arm and subsidiary of State-owned Banque Publique d'Investissement in France. Formerly known as CDC Entreprises SAS, the firm was established in 1994 to carry out public-interest missions such as employment creation and momentum initiation in the private equity field. In 2013 they became BPIfrance Investissement when CDC Entreprises, FSI and FSI Régions merged. Headquartered in Paris, BPIfrance Investissement invests of behalf of the Government of France, as well as for third parties including FEI-Fonds Européen d'Investissement, BEI-Banque Européenne d'Investissement and BPCE SA. The firm invests directly or indirectly in SMEs and intermediate-sized companies at all stages of their development.
81
| Subsidiary | Investment Managers | 81 |
Ecole Polytechnique
54
| College/University | Other Consumer Services | 54 |
Public Company | Pharmaceuticals: Major | 37 | |
15
| Public Company | Pharmaceuticals: Major | 15 |
Calyxt, Inc.
Calyxt, Inc. Miscellaneous Commercial ServicesCommercial Services Calyxt, Inc. is technology company. engages in delivering plant-based solutions. Its products include high oleic soybean oil, high fiber wheat, high oleic soybean meal, and low lignin alfalfa. The company was founded by Daniel F. Voytas and André Choulika on January 8, 2010 and is headquartered in Roseville, MN.
15
| Extinct | Miscellaneous Commercial Services | 15 |
15
| Subsidiary | Pharmaceuticals: Major | 15 |
Kurma Partners SA
Kurma Partners SA Investment ManagersFinance Kurma Partners SA (KP) is an independent venture capital firm founded in 2009 by Thierry Laugel. The firm is headquartered in Paris, France.
14
| Holding Company | Investment Managers | 14 |
ENYO Pharma SA
ENYO Pharma SA BiotechnologyHealth Technology ENYO Pharma SA operates as a biopharmaceutical company. The firm's research and development is focused on human infecting viruses, with the first two programs being dedicated to the treatment of severe and seasonal flu and chronic hepatitis B. The company was founded by Jacky Vonderscher, Jean-Jacques Garaud, Benoît de Chassey, Laurène Meyniel-Schicklin, Patrice André and Vincent Lotteau January 2014 and is headquartered in Lyon, France.
13
| Holding Company | Biotechnology | 13 |
Public Company | Pharmaceuticals: Major | 12 | |
SparingVision SAS
SparingVision SAS BiotechnologyHealth Technology SparingVision SAS develops therapeutic approach for treatment of blinding inherited retinal diseases such as retinitis pigmentosa. The company was founded by Jose Alain Sahel, Thierry Leveillard and Florence Allouche Ghrenassia and is headquartered in Paris, France.
11
| Holding Company | Biotechnology | 11 |
Demeter Ventures SA
Demeter Ventures SA Investment ManagersFinance 123 Investment Managers SA is a Private Equity/Venture Capital firm, a subsidiary of Capucines Capital Partners SAS founded in 2000. 123 Investment Managers SA is headquartered in Grenoble.
10
| Private Company | Investment Managers | 10 |
Aledia SAS
Aledia SAS Electrical ProductsProducer Manufacturing Aledia SAS develops and manufactures light-emitting diodes. Its products are based on 3D architecture using gallium-nitride-on-silicon microwires. The firm's technology uses silicon wafers and existing complementary metal-oxide semiconductor wafer-fabrication processes and tools, enabling production of LED chips. The company was founded by Giorgio Anania, Philippe Gilet, and Xavier Hugon in 2011 and is headquartered in Grenoble, France.
7
| Holding Company | Electrical Products | 7 |
Ribogenics, Inc.
Ribogenics, Inc. BiotechnologyHealth Technology Ribogenics, Inc. is a biotechnology company. The private company is based in Philadelphia, PA. The CEO of the company is Yves Joseph Ribeill.
3
| Private Company | Biotechnology | 3 |
Argobio SAS
Argobio SAS Miscellaneous Commercial ServicesCommercial Services Argobio SAS is a start-up studio founded in 2021 and based in Paris, FR. The company was initiated by Kurma Partners, a leading healthcare venture capital firm based in France, and Bpifrance, the French national investment bank. The French company aims to nurture and launch at least five breakthrough biotech companies over the next five years by sourcing innovative early-stage projects from renowned European academic research institutions. The focus is on selected therapeutic areas, including rare diseases, neurological disorders, oncology, and immunology. Argobio will identify, select, and incubate these projects up to company creation and beyond, providing broad expertise in the discovery and development of novel drugs with a team of highly experienced biotech entrepreneurs. The internal team is led by Yves Ribeill, Neill Mackenzie, Poul Sørensen, and Rémi Soula. Thierry Laugel, Managing Partner at Partners, is the President of Argobio. Kurma and Bpifrance were joined by complementary strategic investors, Angelini Pharma, a private international pharmaceutical company, Evotec, a drug discovery alliance and development partnership company, and the Institut Pasteur, an internationally renowned center for biomedical research.
2
| Holding Company | Miscellaneous Commercial Services | 2 |
Aventis Capital
1
| Extinct | Investment Managers | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Laurent Arthaud via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
Novartis Oncology, Inc.
Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | President Corporate Officer/Principal | |
CDC Enterprises, Inc.
CDC Enterprises, Inc. Electrical ProductsProducer Manufacturing CDC Enterprises, Inc. designs, manufactures, and distributes patented HDPE ductwork products. It offers airtight, mildew, corrosion resistant, and thermal constructed ductwork products. The firm specializes in electrical instrumentation, controls and systems integration, for public works, utilities, private industry, and government organizations. It provides a wide range of services including pump efficiency monitoring, system diagnostics and troubleshooting, GPS mapping, robotic controls, panel design, and fabrication. The company was founded by Jon W. Jungers in April 2001 and is headquartered in Ringwood, IL. | Electrical Products | Chairman Chief Investment Officer Corporate Officer/Principal | |
POXEL | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
University of Oxford | College/University | Graduate Degree Doctorate Degree Graduate Degree | |
Eurazeo Investment Manager - EIM SA
Eurazeo Investment Manager - EIM SA Investment ManagersFinance Eurazeo Investment Managr - EIM SA (Eurazeo IM) is a Venture Capital firm founded in 1997 by Christophe Bavière and part of the Eurazeo Group. Eurazeo Investment Manager - EIM SA is headquartered in Paris with additional offices in Frankfurt, Shanghai and Seoul. The firm is formerly known as Idinvest Partners SA, former AGF Private Equity SA. | Investment Managers | Investment Committee Member Director/Board Member | |
INSEAD | College/University | Doctorate Degree Masters Business Admin Undergraduate Degree Masters Business Admin | |
INNATE PHARMA | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Director of Finance/CFO Director/Board Member | |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal President Corporate Officer/Principal | |
THERADIAG | Medical Specialties | Director/Board Member Director/Board Member Investor Relations Contact | |
ADEMTECH SA
ADEMTECH SA Miscellaneous Commercial ServicesCommercial Services ADEMTECH SA specializes in developing and manufacturing magnetic nanoparticles for diagnostic and scientific research applications. The firm produces magnetic nanoparticles for concentration, separation, purification, microfluidic device integration and identification of molecules and specific cells. The company was founded in 2000 and is headquartered in Pessac, France. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Université Paris 1 Panthéon-Sorbonne | College/University | Doctorate Degree Graduate Degree Graduate Degree | |
ABIONYX PHARMA | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
SUPERSONIC IMAGINE | Medical Specialties | Director/Board Member Director/Board Member Director/Board Member | |
École des Hautes Études Commerciales de Paris | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Graduate Degree | |
Institut National des Sciences Appliquées de Toulouse | College/University | Undergraduate Degree Undergraduate Degree | |
Universität Ulm | College/University | Doctorate Degree Doctorate Degree | |
France Biotech Association
France Biotech Association Miscellaneous Commercial ServicesCommercial Services France Biotech Association is an independent association founded in 1997 that brings together healthtech entrepreneurs and their expert partners. The non-profit company is based in Paris, France. The association actively contributes to meeting the many challenges of the healthtech industry, such as companies' financing, innovation-related taxes, regulatory and market access related issues. It offers concrete competition and solutions through its commissions and working groups to help startups and SMEs become international leaders capable of rapidly developing and bringing innovative solutions to patients. The French company was founded by Philippe Pouletty, Pascal Brandys, Denis J. Lucquin. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Corporate Officer/Principal Director/Board Member | |
Takara Bio Europe AB
Takara Bio Europe AB Miscellaneous Commercial ServicesCommercial Services Takara Bio Europe AB is a provider of stem cell derived products and technologies which will drive unprecedented innovation in drug discovery and regenerative medicine today and in the future. The company was first in the world to bring to the market human embryonic stem (hES) cell-derived hepatocytes and cardiomyocytes for use as drug discovery tools. Cellartis is also the single commercial source of ethically derived hES cell lines and has developed cell lines for a range of uses. This hES cell technology platform offers a path to tools and regenerative medicine discoveries of the future. The company was founded in 2001 and is headquartered in Gothenburg, Sweden. | Miscellaneous Commercial Services | Director/Board Member President Director/Board Member General Counsel Chief Executive Officer | |
CYTOO SA
CYTOO SA Medical SpecialtiesHealth Technology CYTOO SA operates as a contract research organization which develops physiological cell-based assays. It focuses on developing, manufacturing, and commercializing new technologies for cell analysis for life sciences research community. The company has offices in Bethesda and Grenoble. The company was founded by François Chatelain, Alexandra Fuchs and Jacques Lewiner in 2008 and is headquartered in Grenoble, France. | Medical Specialties | Director/Board Member Director/Board Member | |
InGen Biosciences SA
InGen Biosciences SA Medical SpecialtiesHealth Technology InGen Biosciences SA is engaged in the development of in-vitro diagnostic products for use in medical biology laboratories. The company was founded in 1993 and it is headquartered in Chilly-Mazarin, France. | Medical Specialties | Director/Board Member Director/Board Member | |
Bpifrance Participations SA /PRIVATE EQUITY/
Bpifrance Participations SA /PRIVATE EQUITY/ Investment ManagersFinance Bpifrance Participations SA/ PRIVATE EQUITY/ (BPIfrance Participations PE) is the private equity division of Bpifrance Participations SA subsidiary of State-owned Caisse des Dépots & Consignations headquartered in France. Formerly known as Fonds Stratégique d'Investissement SA (Private Equity), the firm was established in 2008 by the Government of France in an aim to strengthen distressed companies of strategic importance for the French economy. Based in Paris, BPIfrance Participations specializes in fund of funds and direct investments in French intermediate-sized companies. | Investment Managers | Director/Board Member Private Equity Investor Private Equity Analyst | |
CEA-Léti
CEA-Léti Miscellaneous Commercial ServicesCommercial Services CEA-Leti is a technology research institute located in Grenoble, France. The institute specializes in miniaturization technologies that enable smart, energy-efficient, and secure solutions for various industries. The institute's multidisciplinary teams deliver solid expertise, leveraging world-class pre-industrialization facilities. CEA-Leti tackles critical challenges in healthcare, energy, and digital migration, from sensors to data processing and computing solutions. The institute has a staff of more than 2,000 talents, a portfolio of 3,200 patents, and 11,000 sq. meters of cleanroom space. CEA-Leti has launched 75 startups and is a member of the Carnot Institutes network. Founded in 1967, CEA-Leti pioneers micro and nanotechnologies to provide differentiating applicative solutions for companies, SMEs, and startups. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
SENSORION | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Amundi Private Equity Funds SA
Amundi Private Equity Funds SA Investment ManagersFinance Amundi Private Equity Funds SA (Amundi PEF) is the private equity subsidiary of Amundi SA, itself a subsidiary of Crédit Agricole SA (XP: ACA) in France. Formerly known as CAAM-CI, founded in 1999 as CPR Private Equity, Amundi PEF was formed in 2009 by combining the Crédit Agricole and Société Générale asset management operations. The firm is headquartered in Paris and has additional offices in Bucharest, Cairo, Casablanca, Tunis and Warsaw. They invest in companies at all stages of development, providing institutional and individual investors with a wide spectrum of investment opportunities. | Investment Managers | Director of Investments Private Equity Analyst | |
ASARINA PHARMA AB | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Younited SA
Younited SA Finance/Rental/LeasingFinance Younited SA is an internet platform that provides financial solutions. It specializes in "peer-to-peer" lending service, enabling investors with savings (individuals, foundations, companies & institutions) to fund personal consumer loans through an online platform. Its services encompass monetary investment and borrowing. The company was founded by Charles Egly and Geoffroy Guigou in October 21, 2009 and is headquartered in Paris, France. | Finance/Rental/Leasing | Director/Board Member Director/Board Member | |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
PricewaterhouseCoopers France SARL
PricewaterhouseCoopers France SARL Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers France provides accounting and business management consulting services. It offers expertise in auditing, financial strategy, legal advise, and investment. The company was founded on May 30, 1963 and is headquartered in Neuilly-sur-Seine, France. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
ADVICENNE | Pharmaceuticals: Generic | Chairman Director/Board Member Director/Board Member | |
Xeltis AG
Xeltis AG Medical SpecialtiesHealth Technology Xeltis AG develops medical devices to transform standards of care in heart valve replacement and vascular surgery. It develops fully bio absorbable synthetic heart valves and vascular grafts intended to enable for the first time the spontaneous growth of natural, healthy valves and vessels. Its medical device platform comprises bioabsorbable heart valves and blood vessels, designed to enable Endogenous Tissue Restoration (ETR), the natural restoration of the complex body part they replace upon implantation. The company was founded by Martijn Cox, Laurent Grandidier and Simon P. Hoerstrup in 2006 and is headquartered in Zurich, Switzerland. | Medical Specialties | Director/Board Member Director/Board Member | |
École des Hautes Études Commerciales du Nord | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree | |
Institut Financement de Cinéma & Industries Culturelles | Director/Board Member Director/Board Member | ||
Bois & Sciages de Sougy SA
Bois & Sciages de Sougy SA Forest ProductsNon-Energy Minerals Bois & Sciages de Sougy SA manufactures wood products. The company was founded on February 14, 1986 and is headquartered in Sougy-sur-Loire, France. | Forest Products | Director/Board Member Director/Board Member | |
GENSIGHT BIOLOGICS S.A. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
Transcelerate Biopharma, Inc.
Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Transcelerate Biopharma, Inc. is a non-profit consortium that collaborates with pharmaceutical and biotechnology companies to improve the delivery of new medicines. The non-profit company is based in King of Prussia, PA. The organization's mission is to identify, prioritize, design, and facilitate implementation of solutions to drive the efficient, effective, and high-quality delivery of new medicines. Transcelerate has 20 member companies and 30+ initiatives focused on improving the patient and site experience, enhancing sponsor efficiencies and drug safety, and harmonizing processes and sharing information. The company was founded by Garry Arthur Neil, and Janice Chang has been the CEO of the company since 2014. | Biotechnology | Director/Board Member Director/Board Member | |
Minoryx Therapeutics SL
Minoryx Therapeutics SL BiotechnologyHealth Technology Minoryx Therapeutics SL engages in the development of drugs for the orphan genetic diseases of the central nervous system. The company was founded by Marc Martinell, Joan Aymami, Nigel Ten Fleming and Xavier Barril in 2011 and is headquartered in Barcelona, Spain. | Biotechnology | Director/Board Member Director/Board Member | |
Cellectis, Inc.
Cellectis, Inc. Pharmaceuticals: MajorHealth Technology Part of Cellectis SA, Cellectis, Inc. engages in the upstream research of genome engineering and in the development of pre-engineered products for pharmaceutical industry, cell therapies, seed companies, and laboratory researchers. The private company is based in New York, NY. André Choulika has been the CEO of the company since 2014. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
Step Pharma SAS
Step Pharma SAS Pharmaceuticals: MajorHealth Technology Step Pharma SAS develops drugs for immunosuppressive therapies. The company was founded by Geoffroy de Ribains, Alain Fischer, and Sylvain Latour and is headquartered in Paris, France. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Director/Board Member Director/Board Member | |
Horama SA
Horama SA BiotechnologyHealth Technology Horama SA engages in the development of gene therapies, It focuses on ophthalmological diseases for preserving visual autonomy of patients. The company was founded by Denis Cayet, Christian Hamel, Guylene Le Meur, Philippe Moullier, Vasiliki Kalatzis, and Michel Weberin March 2014 and is headquartered in Paris, France. | Biotechnology | Director/Board Member Director/Board Member | |
Vivet Therapeutics SAS
Vivet Therapeutics SAS BiotechnologyHealth Technology Vivet Therapeutics SAS develops novel gene therapy treatments for inherited metabolic diseases. The firm offers its services under the categorizers of Biopharma, Biotechnology and Health Care. The company was founded by Jean-Philippe Combal, Gloria Gonzalez-Aseguinolaza and Jens Kurth on July 26, 2016 and is headquartered in Paris, France. | Biotechnology | Director/Board Member Director/Board Member | |
NH THERAGUIX SAS | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member |
Statistieken
Internationaal
Frankrijk | 37 |
Verenigde Staten | 8 |
Zwitserland | 3 |
Verenigd Koninkrijk | 3 |
Duitsland | 2 |
Sectoraal
Health Technology | 28 |
Consumer Services | 9 |
Finance | 7 |
Commercial Services | 6 |
Producer Manufacturing | 2 |
Operationeel
Director/Board Member | 583 |
Corporate Officer/Principal | 162 |
Chairman | 89 |
Independent Dir/Board Member | 88 |
Chief Executive Officer | 67 |
Sterkste connecties
Insiders | |
---|---|
Philippe Peltier | 45 |
Vanessa Giraud | 41 |
Jérôme Gallot | 33 |
Iain Dukes | 30 |
Pierre Bastid | 29 |
Joseph Papa | 28 |
Ann Hanham | 26 |
Steven Gilman | 25 |
Stéphane Boissel | 24 |
Philippe Boucheron | 24 |
Dominique Takizawa | 23 |
Mathieu Simon | 22 |
Pamela Kirby | 22 |
Damian Marron | 21 |
Maïlys Ferrère | 21 |
- Beurs
- Insiders
- Laurent Arthaud
- Bedrijfsconnecties